COMMUNIQUÉS West-GlobeNewswire

MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants
18/07/2019
WESTLAKE VILLAGE, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the repayment of outstanding debt by an aggregate amount of approximately $4.0 million and the repurchase [...]
SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers
18/07/2019
CARLSBAD, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
18/07/2019
EXPLORER-HCM Patient Screening Closes Ahead of Schedule – Initial Results Now Anticipated in the Second Quarter of 2020 Royalty Purchase Creates Additional Economic Value for MyoKardia’s Emerging HCM Treatment Portfolio [...]
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18/07/2019
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET
18/07/2019
CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its second-quarter 2019 financial [...]
Executive Women In Bio Selects Candidates for 2019 Boardroom Ready Program
18/07/2019
NEW YORK, July 18, 2019 (GLOBE NEWSWIRE) -- Executive Women In Bio (EWIB), a group of senior leaders committed to promoting, empowering, and elevating executive women in biopharma and the life sciences operating within [...]
Samumed Announces Publication of Preclinical Data Demonstrating That SM07883 is a Potential Treatment for Alzheimer’s Disease
18/07/2019
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today the publication of preclinical data demonstrating that SM07883 inhibits tau pathology and associated neuroinflammation, both of which are [...]
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data and Artificial Intelligence-Driven Approach to Treating Ovarian Cancer
18/07/2019
PITTSBURGH, July 18, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) subsidiary Helomics, an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving [...]
Chembio Diagnostics and Takeda Pharmaceutical Company Enter Collaboration to Develop Point-of-Care Diagnostic Test
18/07/2019
MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care (POC) diagnostics company focused on infectious diseases, today announced that it has entered into a [...]
The New Hemp Energy Drink Will Be Offered to Consumers in 700 Additional Stores in Five Provinces
18/07/2019
OTTAWA, ON, July 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Heath, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that one of the largest food and convenience store chains in [...]
Progressive Care Inc. Garners Coverage in Publicly Traded Podcasts
18/07/2019
MIAMI, July 18, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Publicly Traded Podcasts’ [...]
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
18/07/2019
These next-generation SPEAR T-cells may improve long term T-cell functions PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 18, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc, Philadelphia, PA, and Oxfordshire [...]
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer
18/07/2019
SAN CARLOS, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]
The Joint Corp. Acquires Four Clinics
18/07/2019
- Enters the Growing Georgia/South Carolina Market with Three Clinics - - Expands the Phoenix, Arizona Corporate Portfolio - SCOTTSDALE, Ariz., July 18, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a [...]
HempAmericana Announces Dramatic Rise in Its CBD Production and Inventory
18/07/2019
NEW YORK, July 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging participant in the CBD products market, is excited to update shareholders on [...]
AuDStandard Announces Partnership With Hear Billing Solutions (HBS)
18/07/2019
PEARLAND, Texas, July 18, 2019 (GLOBE NEWSWIRE) -- AuDStandard, an unbundled hearing aid buying group that provides exclusive pricing, practice growth solutions, detailed analytics and other services to hearing [...]
Olivier Chaudoir Joins BioSig as Director of Marketing
18/07/2019
Electrophysiology marketing leader to drive market adoption strategy for PURE EP™ System Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
Agile Therapeutics Appoints Chief Financial Officer
18/07/2019
Dennis P. Reilly to bring commercial experience to management team Appointment Effective August 5, 2019 PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare [...]
Centrexion Therapeutics to Present New Positive Clinical Trial Results on Streamlined CNTX-4975 Administration Techniques
18/07/2019
-- Administration procedure designed to optimize physician and patient experience and convenience -- -- Company also shares interim analysis of 719 patients in VICTORY-3 Phase 3 open-label trial indicating the studied [...]

Pages